Cat# : THP-0177
|Product Name:||Human Varicella Zoster Immune Globulin|
|Description:||The product is a solvent/detergent-treated sterile liquid preparation of purified human immune globulin G (IgG) containing antibodies to varicella zoster virus (anti-VZV). It is prepared from pools of healthy human donors' plasma via anion-exchange column chromatography.|
|Molecular Weight:||Not Available|
|Cas No:||Not Available|
|Endotoxin Level:||<0.001 EU per 1 μg of the peptide by the LAL method|
|Drug Name:||Human Varicella-Zoster Immune Globulin|
|Applications:||Indicated for preventing and reducing the severity of chicken pox (varicella zoster virus) infections in high risk individuals within 4 days of exposure to varicella zoster virus.|
|Examples of Clinical Use:||Chicken pox (varicella zoster virus) infections|
|Pharmacodynamics:||The product provides passive immunization for non-immune individuals exposed to VZV, reducing the severity of varicella infections.|
|Mechanism of action:||Immunoglobulins are derived from human plasma and synthesized from plasma cells that recognize a broad spectrum of specific antigenic determinants.Derived from a pool of healthy human plasma, Human Varicella-Zoster Immune Globulin is a solvent/detergent-treated sterile lyophilized preparation of purified human immune globulin G (IgG) containing antibodies to varicella zoster virus. The anti-VZV antibodies in VariZIG™ are thought to bind to proteins on the varicella virus; thereby, preventing or reducing the severity and progression of varicella infections.|
|Affected organisms:||Not Available|
For more information on how our products could help advance your project, please contact us.
ENTER YOUR EMAIL HERE TO SUBSCRIBE.
Copyright © Creative BioMart. All Rights Reserved.